FDA Status
Not FDA-Approved
Phase II trial halted after patient fatality
Claimed Benefits
- Sustained GH elevation
- Preserved pulsatile GH secretion
- Potential IGF-1 increase
Clinical Evidence
3
Human Trials
Phase I
Highest Phase
Phase I trials showed 2-10x GH increases lasting 6+ days, but development was suspended after a Phase II fatality.
Read Full Deep Dive
Mechanism, dosing, vendor pricing, and full research citations